Effect of cyclosporine withdrawal on IL-10 production in kidney transplant recipients

被引：2

作者：

Alberlú, J

Richaud-Patin, Y

Mancilla, E

Díliz, H

Correa-Rotter, R

Chew-Wong, A

Uribe, N

de Leo, C

Llorente, L

机构：

[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Transplantat, Mexico City 14000, DF, Mexico

[2] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Immunol, Mexico City 14000, DF, Mexico

[3] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Nephrol, Mexico City 14000, DF, Mexico

[4] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Pathol, Mexico City 14000, DF, Mexico

[5] Inst Nacl Cardiol Ignacio Chavez, Dept Transplantat, Mexico City, DF, Mexico

来源：

TRANSPLANTATION PROCEEDINGS | 2001年 / 33卷 / 1-2期

关键词：

D O I：

10.1016/S0041-1345(00)02775-5

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：2024 / 2027

页数：4

共 11 条

[1] Withdrawal versus continuous cyclosporine therapy in kidney transplant recipients of one-haplotype-matched donors [J].

Chew-Wong, A ;

Alberú, J ;

Abasta-Jiménez, M ;

Alvarez-Sandoval, E ;

Gabilondo-Navarro, F ;

Correa-Rotter, R .

TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) :1106-1109

[2] BENEFICIAL-EFFECTS OF CONVERSION FROM CYCLOSPORINE TO AZATHIOPRINE AFTER KIDNEY-TRANSPLANTATION [J].

HOLLANDER, AAMJ ;

VANSAASE, JLCM ;

KOOTTE, AMM ;

VANDORP, WT ;

VANBOCKEL, HJ ;

VANES, LA ;

VANDERWOUDE, FJ .

LANCET, 1995, 345 (8950) :610-614

[3] Ten-year follow-up of mixed lymphocyte reaction-hyporesponsive living related cyclosporine monotherapy-treated renal allograft recipients [J].

Kerman, RH ;

Katz, SM ;

Schoenberg, L ;

Baraket, O ;

VanBuren, CT ;

Kahan, BD .

TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) :198-199

[4]

Li XC, 1998, J IMMUNOL, V161, P2241

[5]

LLORENTE L, 1993, EUR CYTOKINE NETW, V4, P421

[6] INTERLEUKIN-10 [J].

MOORE, KW ;

OGARRA, A ;

MALEFYT, RD ;

VIEIRA, P ;

MOSMANN, TR .

ANNUAL REVIEW OF IMMUNOLOGY, 1993, 11 :165-190

[7] A CONTROLLED TRIAL OF CYCLOSPORINE IN RENAL-TRANSPLANTATION WITH CONVERSION TO AZATHIOPRINE AND PREDNISOLONE AFTER 3 MONTHS [J].

MORRIS, PJ ;

FRENCH, ME ;

DUNNILL, MS ;

HUNNISETT, AGW ;

TING, A ;

THOMPSON, JF ;

WOOD, RFM .

TRANSPLANTATION, 1983, 36 (03) :273-277

[8] The Banff 97 working classification of renal allograft pathology [J].

Racusen, LC ;

Solez, K ;

Colvin, RB ;

Bonsib, SM ;

Castro, MC ;

Cavallo, T ;

Croker, BP ;

Demetris, AJ ;

Drachenberg, CB ;

Fogo, AB ;

Furness, P ;

Gaber, LW ;

Gibson, IW ;

Glotz, D ;

Goldberg, JC ;

Grande, J ;

Halloran, PF ;

Hansen, HE ;

Hartley, B ;

Hayry, PJ ;

Hill, CM ;

Hoffman, EO ;

Hunsicker, LG ;

Lindblad, AS ;

Marcussen, N ;

Mihatsch, MJ ;

Nadasdy, T ;

Nickerson, P ;

Olsen, TS ;

Papadimitriou, JC ;

Randhawa, PS ;

Rayner, DC ;

Roberts, I ;

Rose, S ;

Rush, D ;

Salinas-Madrigal, L ;

Salomon, DR ;

Sund, S ;

Taskinen, E ;

Trpkov, K ;

Yamaguchi, Y .

KIDNEY INTERNATIONAL, 1999, 55 (02) :713-723

[9] In vivo expression of transforming growth factor-β1 in humans -: Stimulation by cyclosporine [J].

Shin, GT ;

Khanna, A ;

Ding, RC ;

Sharma, VK ;

Lagman, M ;

Li, BG ;

Suthanthiran, M .

TRANSPLANTATION, 1998, 65 (03) :313-318

[10] A longitudinal study of TGF-β1 protein levels in renal allograft recipients converted from CsA to MMF or AZA [J].

van der Mast, BJ ;

van Besouw, NM ;

de Kuiper, P ;

Vaessen, LMB ;

IJzermans, JNM ;

van Gelder, T ;

Weimar, W .

CLINICAL TRANSPLANTATION, 2000, 14 (01) :66-69

← 1 2 →